---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-013879"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:44:11.006511+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne Q1 revenue $289.5M (organic +4%), adj EPS $0.42; declares $0.08 dividend

## Summary
- Q1 revenue $289.5M, up 5% reported (4% organic); GAAP EPS $0.21 vs $0.31; adjusted EPS $0.42 vs $0.41.
- Diagnostics & Spatial Biology segment organic growth 14%; cell and gene therapy workflow solutions strong.
- Dividend of $0.08 per share declared, payable Nov 22 to holders of record Nov 11.
- Annual meeting: board set at 9, all director nominees elected, say-on-pay approved, KPMG ratified.

## SEC filing metadata
- accession: 0001558370-24-013879
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837024013879/0001558370-24-013879-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837024013879/tech-20241025x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-013879
- JSON: https://secwatch.observer/filing/0001558370-24-013879.json
- Plain text: https://secwatch.observer/filing/0001558370-24-013879.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.